Showing results (1181-1190 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|November 5, 2008
Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicityAndrea L Ciaranello, George R Seage, Kenneth A Freedberg, et al.AIDS (London, England)|November 5, 2008
Potential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1Thor A Wagner, Lisa M FrenkelAIDS (London, England)|September 25, 2007
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and ThailandNathan Ford, David Wilson, Gabriela Costa Chaves, et al.AIDS (London, England)|September 25, 2007
Treatment at scale in Brazil: a physician's perspectiveMauro SchechterAIDS (London, England)|September 25, 2007
Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experienceSikhamani Rajasekaran, Lakshmanan Jeyaseelan, Sundaraj Vijila, et al.AIDS (London, England)|September 22, 2007
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation statusDelphine Sauce, Jorge R Almeida, Martin Larsen, et al.AIDS (London, England)|September 22, 2007
Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy studyNeil A Martinson, Alan Karstaedt, W D Francois Venter, et al.AIDS (London, England)|September 22, 2007
C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor settingPaul K Drain, Roland Kupka, Gernard I Msamanga, et al.AIDS (London, England)|September 22, 2007
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapineTamara S Flys, Anthony Mwatha, Laura A Guay, et al.AIDS (London, England)|August 1, 1991
Beta 2-microglobulin levels in drug users: the influence of risk behaviourP J Flegg, R P Brettle, J R Robertson, et al.Pageof 1,044